Home
/ Sanofi
/ Competitors

Sanofi Competitors and Similar CompaniesClear all

Sanofi's competitors and similar companies include Lilly and Novartis.

	Sanofi Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.	Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.	Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Founding Date	Founding Date 1994	Founding Date 1876	Founding Date 1996
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development life sciences pharma therapy	Tags Manufacturing & Industrial diabetes drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations Paris, FR HQ Hydra, DZ Buenos Aires, AR Macquarie Park, AU Melbourne, AU Virginia, AU Wien, AT see more	Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more	Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more
Employees	Employees 82,878	Employees 47,0009% increase	Employees 75,883
Valuation ($)	Valuation ($) 141.1 b	Valuation ($) 903.4 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) €45.4b (FY, 2025)	Revenue (est.) $65.2b (FY, 2025)	Revenue (est.) $56.7b (FY, 2025)
Cost of goods	Cost of goods €11.6b (FY, 2025)	Cost of goods $11.1b (FY, 2025)	Cost of goods $8.4b (FY, 2025)
Gross profit	Gross profit €37.6b (FY, 2025)	Gross profit $54.1b (FY, 2025)	Gross profit $49.8b (FY, 2025)
Net income	Net income €8b (FY, 2025)	Net income $20.6b (FY, 2025)	Net income $14b (FY, 2025)
Operating ⚠
Phase III Trials Products	Phase III Trials Products N/A	Phase III Trials Products 10 (FY, 2021)	Phase III Trials Products 44 (FY, 2022)
Funding
Total funding raised	Total funding raised $ 310m	Total funding raised N/A	Total funding raised $ 6.5m